Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown CNS Pharmaceuticals Inc. CNSP

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.


Top institutional share ownership of CNS Pharmaceuticals Inc

Name Shares Shares % change Value Value % change
Vanguard Group Inc 427,703 0.0% $120 -17.8%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 422,266 0.1% $144 -51.7%
Bank of New York Mellon Corp 203,548 -13.3% $57 -28.8%
VEXMX - Vanguard Extended Market Index Fund Investor Shares 182,006 0.0% $128 -53.1%
Virtu Financial LLC 178,184 59.5% $50 31.6%
Geode Capital Management, Llc 129,016 0.0% $36 -16.3%
FSMAX - Fidelity Extended Market Index Fund 65,642 0.0% $20 -24.0%
FNCMX - Fidelity Nasdaq Composite Index Fund 40,696 114.9% $12 71.4%
FSM Wealth Advisors, LLC 40,000 $10
IWC - iShares Micro-Cap ETF 38,201 -1.8% $13 -51.9%

Top institutional buyers of CNS Pharmaceuticals Inc

Name Shares % change Value % change Shares Value
FNCMX - Fidelity Nasdaq Composite Index Fund 114.9% 71.4% 40,696 $12
Virtu Financial LLC 59.5% 31.6% 178,184 $50
HighTower Advisors, LLC 18.5% 0.0% 16,000 $4
Tower Research Capital LLC (TRC) 2.1% -20.0% 29,007 $8
Wells Fargo & Company/mn 0.3% -25.0% 12,196 $3
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 0.1% -51.7% 422,266 $144

Top institutional sellers of CNS Pharmaceuticals Inc

Name Shares % change Value % change Shares Value
Citadel Advisors Llc -62.5% -66.7% 20,721 $6
JETSX - Total Stock Market Index Trust NAV -30.0% -66.7% 3,118 $2
Bank of New York Mellon Corp -13.3% -28.8% 203,548 $57
IWC - iShares Micro-Cap ETF -1.8% -51.9% 38,201 $13

Information provided by Fintel.io